Published in Biochemistry on September 19, 1989
The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120. J Virol (2002) 7.82
Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis. Biochem J (1994) 1.00
Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein. Biochem J (1992) 0.99
Increased productivity of recombinant tissular plasminogen activator (t-PA) by butyrate and shift of temperature: a cell cycle phases analysis. Cytotechnology (2001) 0.98
Carbohydrate analysis throughout the development of a protein therapeutic. Glycoconj J (2009) 0.97
Synthesis and secretion of wild-type and mutant human plasma cholesteryl ester transfer protein in baculovirus-transfected insect cells: the carboxyl-terminal region is required for both lipoprotein binding and catalysis of transfer. Proc Natl Acad Sci U S A (1992) 0.94
Differential site accessibility mechanistically explains subcellular-specific N-glycosylation determinants. Front Immunol (2014) 0.89
High-level expression of enzymatically active mature human gamma-glutamyltransferase in transgenic V79 Chinese hamster cells. Proc Natl Acad Sci U S A (1991) 0.80
Separation and characterization of the two Asn-linked glycosylation sites of chicken serum riboflavin-binding protein. Glycosylation differences despite similarity of primary structure. Biochem J (1992) 0.78
Binding of tissue plasminogen activator to human aortic endothelial cells. Biochem J (1990) 0.75
In silico analysis of the polygalacturonase inhibiting protein 1 from apple, Malus domestica. BMC Res Notes (2015) 0.75
The glycosylation of Bowes melanoma tissue plasminogen activator: lectin mapping, reaction with anti-L2/HNK-1 antibodies and the presence of sulphated/glucuronic acid containing glycans. Biochem J (1996) 0.75
Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells. Biochem J (1992) 0.75
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02
Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet (2004) 7.33
The complete DNA sequence of Autographa californica nuclear polyhedrosis virus. Virology (1994) 5.93
Crow deaths as a sentinel surveillance system for West Nile virus in the northeastern United States, 1999. Emerg Infect Dis (2001) 5.83
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest (1989) 5.71
Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Science (2001) 5.39
Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature (1985) 5.32
Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med (1987) 4.58
Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis. Infect Immun (1995) 4.58
Glycobiology. Annu Rev Biochem (1988) 4.51
Glycosylation and the immune system. Science (2001) 4.39
Glycosyl-phosphatidylinositol moiety that anchors Trypanosoma brucei variant surface glycoprotein to the membrane. Science (1988) 3.41
Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States. Ann Intern Med (1998) 3.41
Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med (1995) 3.38
Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ (1989) 3.32
Attenuation of isoproterenol-mediated vasodilatation in blacks. N Engl J Med (1995) 3.25
Engineering herbicide tolerance in transgenic plants. Science (1986) 3.07
A full genome search in multiple sclerosis. Nat Genet (1996) 2.96
A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J Exp Med (1988) 2.90
Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1. Nature (1985) 2.87
Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med (1992) 2.84
Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature (2001) 2.78
Induction of a 26-kDa-protein mRNA in human cells treated with an interleukin-1-related, leukocyte-derived factor. Eur J Biochem (1985) 2.77
Bcl-2 family proteins are essential for platelet survival. Cell Death Differ (2007) 2.67
Concepts and principles of O-linked glycosylation. Crit Rev Biochem Mol Biol (1998) 2.66
Locations and contexts of sequences that hybridize to poly(dG-dT).(dC-dA) in mammalian ribosomal DNAs and two X-linked genes. Nucleic Acids Res (1988) 2.64
Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. J Biol Chem (1986) 2.61
Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol (1979) 2.53
The evolution of Titan's mid-latitude clouds. Science (2005) 2.46
A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal Biochem (1996) 2.44
Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family. J Clin Invest (1997) 2.42
Intestinal permeability in children with Crohn's disease and coeliac disease. Br Med J (Clin Res Ed) (1982) 2.36
Glycosylation: heterogeneity and the 3D structure of proteins. Crit Rev Biochem Mol Biol (1997) 2.36
Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus. J Infect Dis (1982) 2.29
West Nile virus surveillance in Connecticut in 2000: an intense epizootic without high risk for severe human disease. Emerg Infect Dis (2001) 2.26
Quantitative studies of in vitro transformation by chemical carcinogens. J Natl Cancer Inst (1969) 2.26
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia (2009) 2.24
Stimulus control of temporally spaced responding in second-order schedules. J Exp Anal Behav (1967) 2.20
Intracellular staining reveals different levels of stratification for on- and off-center ganglion cells in cat retina. J Neurophysiol (1978) 2.19
Complete structure of the glycosyl phosphatidylinositol membrane anchor of rat brain Thy-1 glycoprotein. Nature (1988) 2.17
Conservation. High value and long life--double jeopardy for tunas and billfishes. Science (2011) 2.14
Interleukin 1 and poly(rI).poly(rC) induce production of a hybridoma growth factor by human fibroblasts. Eur J Immunol (1987) 2.13
Human vascular permeability factor. Isolation from U937 cells. J Biol Chem (1989) 2.12
A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record. Clin Pharmacol Ther (2012) 2.12
The Abbott IMx automated benchtop immunochemistry analyzer system. Clin Chem (1988) 2.12
Sequencing of N-linked oligosaccharides directly from protein gels: in-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography. Anal Biochem (1997) 2.12
The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions. J Biol Chem (1998) 2.10
Space flight alters bacterial gene expression and virulence and reveals a role for global regulator Hfq. Proc Natl Acad Sci U S A (2007) 2.05
N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J Biol Chem (1994) 2.05
The high degree of internal flexibility observed for an oligomannose oligosaccharide does not alter the overall topology of the molecule. Eur J Biochem (1998) 2.00
Conservation of 70S ribosomal RNA genes in the chloroplast DNAs of higher plants. Proc Natl Acad Sci U S A (1974) 1.95
Intestinal permeability in the newborn. Arch Dis Child (1984) 1.94
Characterization of a rabbit model of staphylococcal osteomyelitis. J Orthop Res (1997) 1.86
Purification and sequence analysis of bioactive atrial peptides (atriopeptins). Science (1984) 1.85
Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem (1997) 1.84
Cat cones have rod input: a comparison of the response properties of cones and horizontal cell bodies in the retina of the cat. J Comp Neurol (1977) 1.84
A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. J Immunol (1997) 1.83
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain (2003) 1.82
Cystic fibrosis and coeliac disease: coexistence in two children. Arch Dis Child (1973) 1.80
Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke (2003) 1.78
Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications. Hepatology (2001) 1.75
Aminosugar derivatives as potential anti-human immunodeficiency virus agents. Proc Natl Acad Sci U S A (1988) 1.75
American Academy of Pediatrics. Pediatric Practice Action Group and Task Force on Medical Informatics. Privacy protection and health information: patient rights and pediatrician responsibilities. Pediatrics (1999) 1.73
Paediatric survival and re-admission risks following hospitalization on the Kenyan coast. Trop Med Int Health (2000) 1.73
Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus. J Virol (1985) 1.73
Protein synthesis elongation factor EF-1 alpha is essential for ubiquitin-dependent degradation of certain N alpha-acetylated proteins and may be substituted for by the bacterial elongation factor EF-Tu. Proc Natl Acad Sci U S A (1994) 1.72
Determination of the number of endothelial cells in culture using an acid phosphatase assay. Anal Biochem (1986) 1.71
Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science (1997) 1.70
Vibrio parahaemolyticus gastroenteritis in Maryland. I. Clinical and epidemiologic aspects. Am J Epidemiol (1972) 1.70
Analysis of the polyhedrin gene promoter of the Autographa californica nuclear polyhedrosis virus. Nucleic Acids Res (1987) 1.68
Successful detection of small acoustic tumors using the stacked derived-band auditory brain stem response amplitude. Am J Otol (1997) 1.68
Some factors controlling preference between fixed-ratio and variable-ratio schedules of reinforcement. J Exp Anal Behav (1968) 1.68
Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor. Mol Immunol (1985) 1.68
A statistical analysis of N- and O-glycan linkage conformations from crystallographic data. Glycobiology (1999) 1.67
Tissue-specific N-glycosylation, site-specific oligosaccharide patterns and lentil lectin recognition of rat Thy-1. EMBO J (1987) 1.66
Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc Natl Acad Sci U S A (1994) 1.66
Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc Natl Acad Sci U S A (1994) 1.65
Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking. Nat Med (1998) 1.64
Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest (1999) 1.64
Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol (1995) 1.64
Human tissue-type plasminogen activator gene located near chromosomal breakpoint in myeloproliferative disorder. Am J Hum Genet (1986) 1.64
Structure, biosynthesis, and function of glycosylphosphatidylinositols. Biochemistry (1990) 1.63
Inhibition of enzymatic degradation of adhesive-dentin interfaces. J Dent Res (2009) 1.60
Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci U S A (1999) 1.60
Specific incorporation of selenium into lysine- and glutamate- accepting tRNAs from Escherichia coli. J Biol Chem (1983) 1.59
The glycosylation of the influenza A virus hemagglutinin by mammalian cells. A site-specific study. J Biol Chem (1997) 1.58
Conformation-independent binding of monoglucosylated ribonuclease B to calnexin. Cell (1997) 1.58
On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit Rev Oncol Hematol (2011) 1.58
A comparison of electrical properties of neurons in Necturus retina. J Neurophysiol (1973) 1.57
The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev (1999) 1.57